Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Other Non-Current Assets: 2022-2025

  • Abivax's Other Non-Current Assets was N/A to $902,517 in Q1 2025 from the same period last year, while for Mar 2025 it was $902,517, marking a year-over-year change of. This contributed to the annual value of $6.3 million for FY2024, which is 54.32% down from last year.
  • According to the latest figures from Q1 2025, Abivax's Other Non-Current Assets is $902,517, which was down 85.73% from $6.3 million recorded in Q4 2024.
  • Abivax's 5-year Other Non-Current Assets high stood at $13.8 million for Q4 2023, and its period low was $902,517 during Q1 2025.
  • In the last 3 years, Abivax's Other Non-Current Assets had a median value of $3.8 million in 2024 and averaged $5.6 million.
  • In the last 5 years, Abivax's Other Non-Current Assets grew by 15.93% in 2023 and then plummeted by 54.32% in 2024.
  • Over the past 4 years, Abivax's Other Non-Current Assets (Quarterly) stood at $11.9 million in 2022, then increased by 15.93% to $13.8 million in 2023, then slumped by 54.32% to $6.3 million in 2024, then reached $902,517 in 2025.
  • Its Other Non-Current Assets was $902,517 in Q1 2025, compared to $6.3 million in Q4 2024 and $1.2 million in Q2 2024.